119th Congress · introduced in the House · Jan 15, 2026
Expanding Veterans’ Access to Emerging Treatments Act
Official title from Congress.gov
Latest action (Feb 2, 2026): Referred to the Subcommittee on Health.
View on Congress.govPolicy area: Armed Forces and National Security
No official summary has been published for this bill.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Referred to the Subcommittee on Health.
Referred to the House Committee on Veterans' Affairs.
Introduced in House
Introduced in House
Actions from Congress.gov, newest first.
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 24, 2026.
35 citations; showing the 25 most recently posted.
CLEARMIND MEDICINE, INC · lobbying firm or registrant: RK STRATEGIES, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$20,000
Paid to lobbying firm
H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R. 2623, Innovative Therapies Centers of Excellence Act of 2025 H.R. 8800, National Defense Authorizati…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CLEARMIND MEDICINE, INC · lobbying firm or registrant: RK STRATEGIES, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Defense
$20,000
Paid to lobbying firm
H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R. 2623, Innovative Therapies Centers of Excellence Act of 2025 H.R. 8800, National Defense Authorizati…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CLEARMIND MEDICINE, INC · lobbying firm or registrant: RK STRATEGIES, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Alcohol and Drug Abuse
$20,000
Paid to lobbying firm
H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R. 2623, Innovative Therapies Centers of Excellence Act of 2025 H.R. 8800, National Defense Authorizati…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CLEARMIND MEDICINE, INC · lobbying firm or registrant: RK STRATEGIES, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Veterans
$20,000
Paid to lobbying firm
H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R. 2623, Innovative Therapies Centers of Excellence Act of 2025 H.R. 8800, National Defense Authorizati…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NEXALIN TECHNOLOGY INC. · lobbying firm or registrant: RK STRATEGIES, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Health Issues
$20,000
Paid to lobbying firm
H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R. 8469, Making appropriations for military construction, the Department of Veterans Affairs, and relat…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NEXALIN TECHNOLOGY INC. · lobbying firm or registrant: RK STRATEGIES, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Defense
$20,000
Paid to lobbying firm
H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R. 8469, Making appropriations for military construction, the Department of Veterans Affairs, and relat…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NEXALIN TECHNOLOGY INC. · lobbying firm or registrant: RK STRATEGIES, INC.
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 20, 2026 · issue area: Veterans
$20,000
Paid to lobbying firm
H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R. 8469, Making appropriations for military construction, the Department of Veterans Affairs, and relat…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DISABLED AMERICAN VETERANS · lobbying firm or registrant: DISABLED AMERICAN VETERANS
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 16, 2026 · issue area: Veterans
$164,754
Spent on own lobbying
…R. 6644, H.R. 6648, H.R. 6649, H.R. 6652, H.R. 6662, H.R. 680, H.R. 683, H.R. 6835, H.R. 6843, H.R. 6848, H.R. 6858, H.R. 695, H.R. 6993, H.R. 7047, H.R. 7049, H.R. 7091, H.R. 7280, H.R. 740, H.R. 748, H.R. 7489, H.R. 770, H.R. 7735, H.R. 7815, H.R. 7841, H.R. 790, H.R. 803, H.R. 8066, H.R. 8092, H.R. 8120, H.R. 818, H.R. 828,…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
DISABLED AMERICAN VETERANS · lobbying firm or registrant: DISABLED AMERICAN VETERANS
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 21, 2026 · issue area: Veterans
$149,180
Spent on own lobbying
…R. 6655, H.R. 6648, H.R. 6649, H.R. 6652, H.R. 6662, H.R. 680, H.R. 683, H.R. 6835, H.R. 6843, H.R. 6848, H.R. 6858, H.R. 695, H.R. 6993, H.R. 7047, H.R. 7049, H.R. 7091, H.R. 7280, H.R. 740, H.R. 748, H.R. 7489, H.R. 770, H.R. 7735, H.R. 7815, H.R. 7841, H.R. 790, H.R. 803, H.R. 8066, H.R. 818, H.R. 828, H.R. 8372, H.R. 865, H…
Congress inferred from the report year; bill number matches Congress.gov records and the bill predates the report; no title was cited with it. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CLEARMIND MEDICINE, INC · lobbying firm or registrant: RK STRATEGIES, INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 18, 2026 · issue area: Health Issues
$20,000
Paid to lobbying firm
H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R.2623, Innovative Therapies Centers of Excellence Act of 2025 H.R. 8800, National Defense Authorizatio…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CLEARMIND MEDICINE, INC · lobbying firm or registrant: RK STRATEGIES, INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 18, 2026 · issue area: Defense
$20,000
Paid to lobbying firm
H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R.2623, Innovative Therapies Centers of Excellence Act of 2025 H.R. 8800, National Defense Authorizatio…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CLEARMIND MEDICINE, INC · lobbying firm or registrant: RK STRATEGIES, INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 18, 2026 · issue area: Alcohol and Drug Abuse
$20,000
Paid to lobbying firm
H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R.2623, Innovative Therapies Centers of Excellence Act of 2025 H.R. 8800, National Defense Authorizatio…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CLEARMIND MEDICINE, INC · lobbying firm or registrant: RK STRATEGIES, INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 18, 2026 · issue area: Veterans
$20,000
Paid to lobbying firm
H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R.2623, Innovative Therapies Centers of Excellence Act of 2025 H.R. 8800, National Defense Authorizatio…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ADIAL PHARMACEUTICALS, INC. · lobbying firm or registrant: RK STRATEGIES, INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 18, 2026 · issue area: Health Issues
$10,000
Paid to lobbying firm
FDA Issues Related to Addiction H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R. 8800, National Defense Authorization Act for Fiscal Year 2027
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ADIAL PHARMACEUTICALS, INC. · lobbying firm or registrant: RK STRATEGIES, INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 18, 2026 · issue area: Defense
$10,000
Paid to lobbying firm
FDA Issues Related to Addiction H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R. 8800, National Defense Authorization Act for Fiscal Year 2027
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NEXALIN TECHNOLOGY INC. · lobbying firm or registrant: RK STRATEGIES, INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 18, 2026 · issue area: Health Issues
$20,000
Paid to lobbying firm
H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R.8469, Making appropriations for military construction, the Department of Veterans Affairs, and relate…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NEXALIN TECHNOLOGY INC. · lobbying firm or registrant: RK STRATEGIES, INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 18, 2026 · issue area: Defense
$20,000
Paid to lobbying firm
H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R.8469, Making appropriations for military construction, the Department of Veterans Affairs, and relate…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NEXALIN TECHNOLOGY INC. · lobbying firm or registrant: RK STRATEGIES, INC.
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 18, 2026 · issue area: Veterans
$20,000
Paid to lobbying firm
H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R.8469, Making appropriations for military construction, the Department of Veterans Affairs, and relate…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ADIAL PHARMACEUTICALS, INC. · lobbying firm or registrant: RK STRATEGIES, INC.
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Health Issues
$10,000
Paid to lobbying firm
FDA Issues Related to Addiction H.R. 7091, Expanding Veterans Access to Emerging Treatments Act National Defense Authorization Act, FY27
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
ADIAL PHARMACEUTICALS, INC. · lobbying firm or registrant: RK STRATEGIES, INC.
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Defense
$10,000
Paid to lobbying firm
FDA Issues Related to Addiction H.R. 7091, Expanding Veterans Access to Emerging Treatments Act National Defense Authorization Act, FY27
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CLEARMIND MEDICINE, INC · lobbying firm or registrant: RK STRATEGIES, INC.
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Health Issues
$10,000
Paid to lobbying firm
H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R.2623, Innovative Therapies Centers of Excellence Act of 2025 Departments of Labor, Health and Human S…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CLEARMIND MEDICINE, INC · lobbying firm or registrant: RK STRATEGIES, INC.
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Defense
$10,000
Paid to lobbying firm
H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R.2623, Innovative Therapies Centers of Excellence Act of 2025 Departments of Labor, Health and Human S…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CLEARMIND MEDICINE, INC · lobbying firm or registrant: RK STRATEGIES, INC.
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Alcohol and Drug Abuse
$10,000
Paid to lobbying firm
H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R.2623, Innovative Therapies Centers of Excellence Act of 2025 Departments of Labor, Health and Human S…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CLEARMIND MEDICINE, INC · lobbying firm or registrant: RK STRATEGIES, INC.
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Veterans
$10,000
Paid to lobbying firm
H.R. 7091, Expanding Veterans Access to Emerging Treatments Act H.R.2623, Innovative Therapies Centers of Excellence Act of 2025 Departments of Labor, Health and Human S…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
NEXALIN TECHNOLOGY INC. · lobbying firm or registrant: RK STRATEGIES, INC.
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 20, 2026 · issue area: Health Issues
$20,000
Paid to lobbying firm
H.R. 7091, Expanding Veterans Access to Emerging Treatments Act Military Construction, Veterans Affairs, and Related Agencies Appropriations Bill for FY 2027 National De…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing